CEO's investor briefing on Next Science - March 2019
CEO Judith Mitchell talks about Next Science’s medical technology platform that’s already helped 70,000 patients with chronic wound infections as well as the company’s long-term plans for growth.
Chairman’s investor briefing on Next Science - March 2019
With the opening of Next Science’s IPO today, Chairman George Savvides discusses the company’s business strength and fundamentals.
Next Science’s Chief Technology Officer explains breakthrough technology combatting chronic infections - March 2019
Founder and Chief Technology Officer Dr Matthew Myntti outlines the robust science behind the company’s Xbio-based products that destroy, treat and protect people against biofilm-shielded bacterial infections.